Abraham, J. (2007) Building on sociological understandings of the pharmaceutical industry or reinventing the wheel? Responses to Joan Busfield’s ‘Pills, Power and People’. Sociology. 41: 727-36.
Abraham, J. (2002) The pharmaceutical industry as a political player. Lancet. 360: 1498-502.
Abraham, J. (1997) The science and politics of medicines regulation, in M.A. Elston (eds.) Sociology of Health and Illness Special Monograph Issue on the Sociology of Medical Science and Technology, pp. 153-82. Oxford: Blackwell.
Abraham, J.W. (1995) Science, Politics and the Pharmaceutical Industry: Controversy and Bias in Drug Regulation. London: UCL Press.
Abraham, J. (1994) Bias in science and medical knowledge: The Opren Controversy. Sociology. 28: 717-36.
Abraham, J. (1993) Scientific standards and institutional interests: Carcinogenic risk assessment for Benoxaprofen in the UK and the US. Social Studies of Science. 23: 387-444.
Abraham J. and Davis, C. (2005) A comparative analysis of drug safety withdrawals in the UK and the US (1971-1992): Implications for current regulatory thinking and policy. Social Science and Medicine. 61: 881-92.
Abraham, J. and Lewis, G (2002) Citizenship, medical expertise and the regulatory state in Europe. Sociology. 36, 1: 67-88.
Abraham, J. and Reed, T. (2003) Globalization of medicines control, in J. Abraham and H. Lawton Smith (eds. ) Regulation of the Pharmaceutical Industry. Basingstoke: Palgrave.
Abraham, J. and Reed, T. (2001) Trading risks for markets: The international harmonisation of pharmaceuticals regulation. Health, Risk and Society: Special issue on Globalisation. 3: 113-28.
Abraham, J. and Sheppard, J (1999) Therapeutic Nightmare: The Battle of the Worlds most Controversial Sleeping Pill. London: Earth Scan.
Academy of Medical Sciences (2008) Brain Science, Addictions and Drugs. London: AMS.
Biehl, J. (2004) The activist state: Global pharmaceuticals, AIDS and citizenship in Brazil. Social Texts. 22, 3: 105-32.
Blech, J (2006) Inventing Diseases and Pushing Pills: Pharmaceutical Companies and the Medicalisation of Normal Life. London: Routledge.
British Medical Association (2007) Boosting Your Brain Power: Ethical Aspects of Cognitive Enhancements. London: BMA.
Brown, N. and Michael, M. (2003) A sociology of expectations: retrospecting prospects and prospecting retrospects. Technology Assessment and Strategic Management. 15, 1: 3-18.
Brown, N. and Webster, A. (2004) New Medical Technologies and Society. Cambridge: Polity Press.
Brown, P., Zavestoski, S., McCormick, S.,Mayer, B., Morello-Frosch,, R. and Altman, R. (2004) Embodied health movements: new approaches to social movements in health, Sociology of Health and Illness 26, 50-80.
Busfield, J. (2007a) Pills, Power and People: Sociological understandings of the pharmaceutical industry. Sociology. 40: 297-314.
Busfield, J. (2007b) Sociological understandings of the pharmaceutical industry: A response to John Abraham. 41: 737-39.
Busfield, J. (2003) Globalization and the pharmaceutical industry revisited, International Journal of Health Services, 33, 3: 581-603.
Clarke, A, Fishman, J. Fosket, J.R., Mamo, L. and Shim, J. (2003) Biomedicalization: Technoscientific transformations of health, illness, nd US biomedicine. American Sociological Review. 68 (April): 161-94.
Conrad, P. (2007) The Medicalisation of Society. Baltimore: Johns Hopkins University Press.
Conrad, P. (2005) The shifting engines of medicalization. Journal of Health and Social Behavior. 46: 3-14.
Conrad, P. (1992) Medicalisation and social control. Annual Review of Sociology. 18: 209-32.
Conrad, P. and Leiter, V. (2004) Medicalization, markets and consumers. Journal of Health and Social Behavior. 45: 158-76.
Conrad, P. and Schneider, J. (1980a) Deviance and Medicalization: From Badness to Sickness. St Louis: Mosby.
Conrad, P and Schneider, J (1980b) Looking at levels of medicalisation: a comment on Strong’s critique of the thesis of medical imperialism. Social Science and Medicine. 14: 75-9.
Cooperstock, R. and Lennard, H. (1979) Some social meanings of tranquilliser use, Sociology of Health and Illness 1, 2, 238-44.
Buroway, M. (2005) ‘American Presidential Address: For Public Sociology’. British Journal of Sociology. 56, 2: 259-94.
Dunnell, K and Cartwright, A (1972) Medicine-Takers, Prescribers and Hoarders. London: Routledge and Kegan Paul.
Ettorre, E. and Riska, E. (1995) Gendered Moods. Psychotropics and Society. London: Routledge.
Department of Trade and Industry (Office of Science and Technology) (2005) Drugs Futures 2025. London: DTI.
Fox, N.J., Ward, K.J. and O’Rourke, A.J. (2007) A sociology of technology governance for the information age: The case of pharmaceuticals, consumer advertising and the Internet. Sociology. 40: 315-334.
Fox, N.J, Ward, K.J and O’Rourke, A.J. (2005a) The `expert pateint’: empowerment or medical dominance? The case of weight loss, phamaceutical drugs and the Internet, Social Science and Medicine 60, 1299-1309.
Fox, N.J, Ward, K.J and O’Rourke, A.J. (2005b) Pro-Anorexia, Weight-loss drugs and the Internet: An ‘Anti-recovery’ explanatory model of Anorexia. Sociology of Health and Illness. 27, 2: 944-71.
Freidson, E. (1970) Professional Dominance. New York: Dodds Mead.
Gabe, J. and Bury, M. (1996a) Halcion nights: a sociological account of a medical controversy. Sociology. 30: 447-69.
Gabe, J. and Bury, M. (1996b) Risking tranquilliser use: cultural and lay dimensions. In Williams, S. and Calnan, M. (eds.) Modern Medicine. Lay Perspectives and Experiences. London: UCL Press.
Gabe, J., Gustafsson, U. and Bury, M. (1991) Mediating illness: newspaper coverage of tranquilliser dependence, Sociology of Health and Illness, 13, 4: 332-53.
Gabe, J and Lipshitz-Phillips, S. (1982) Evil necessity? The meaning of benzodiazepine use for women patients from one general practice. Sociology of Health and Illness, 4: 201-9.
Gabe, J. and Lipshitz-Phillips, S. (1984) Tranquillisers as social control? Sociological Review, 32: 524-46.
Gabe, J. and Thorogood, N. (1986) Prescribed drug use and the management of everyday life: the experiences of black and white working class women, Sociological Review 34: 737-72.
Harding, G and Taylor, K. (1997) Responding to change: the case of community pharmacy in Britain, Sociology of Health and Illness 19, 5: 547-60
Healy, D. (2006) The latest mania: Selling biopolar disorder. Public Library of Science – Medicine. 3, 4 (April), e185.
Hedgecoe, A. (2007) The Politcs of Personalised Medicine. Cambridge: Cambridge University Press.
Helman, C. (1981) `Tonic’, `fuel’ and `food’: social and symbolic aspects of the long term use of psychotropic drugs, Social Science and Medicine 15B: 521-33.
Hibbert, D, Bissell, P and Ward, P. (2002) Consumerism and professional work in the community pharmacy, Sociology of Health and Illness 24, 1: 46-65.
House of Commons Health Committee (2005) The Influence of the Pharmaceutical Industry (Fourth Report for Session 2004-5). London: The Stationary Office Ltd.
Illich, I (1975) Medical Nemesis. London: Marion Boyars.
Kelleher, D. (2004) Self help groups and their relationship to medicine. In Kelleher, D., Gabe, J. and Williams, G. (eds.) (2004) Challenging Medicine, Second Edition, London: Routledge.
Law, J. (2006) The Big Pharma. London: Constable & Robinson.
Lexchin, J. (2006) Bigger and better: how Pfizer redefined erectile dysfunction. Public Library of Science – Medicine. 3, 4 (April) e. 132
Martin, E. (2007) Bipolar. Princeton: Princeton University Press.
Miah, A and Rich E. (2008) The Medicalization of Cyberspace. London: Routledge.
Mills, C.W. (1959) The Sociological Imagination. Oxford: Oxford University Press.
Morgan, M. (1996) Perceptions and use of anti-hypertensive drugs among cultural groups. In Williams, S. and Calnan, M. (eds.) Modern Medicine. Lay Perspectives and Experiences. London: UCL Press.
Moynihan, R. (2002) Disease-mongering: how doctors, drug companies, and insurers are making you feel sick. British Medical Journal. 324 (April 13th): 923.
Moynihan, R. and Henry, D. (2006) The fight against disease mongering: Generating knowledge for action. Public Library of Science – Medicine. 3, 4 (April), e 191.
Moynihan, R., Health, I and Henry, D (2002) Selling sickness: the pharmaceutical industry and disease mongering. British Medical Journal. 324 (13 April): 886-91.
Nelkin, D. (1995) Selling Science: How the Press Covers Science and Technology. New York: W.H. Freeman.
Novas, C (2001) The political economy of hope: patients’ organisations, science and biovalue. BioSocieties. 1, 3: 289-305.
Petryna, A. (2002) Life Exposed: Biological Citizens After Chernobyl. Princeton: Princeton University Press.
Petryna, A., Lakoff, A and Kleinman, A. (eds.) (2006) Global Pharmaceuticals: Ethics, Markets, Practices. Durham and London; Duke University Press
Phillips, C.B (2006) Medicine goes to school: Teachers as sickness brokers for ADHD. Public Library of Science – Medicine. 3, 4 (April): e.182.
Rief, S. (2008) Outline of a critical sociology of consumption: beyond moralism and celebration, Sociology Compass 2, 1-17.
Rose, N. (2007) The Politics of Life Itself. Princeton: Princeton University Press.
Shah, S. (2007) Body Hunters: Testing New Drugs on the World’s Poorest Patients. London/New York: The New Press.
Sneddon, (2000) The challenge of pharmacogenetics and pharmacogenomics. New Genetics and Society. 19: 145-64.
Stevenson, F., Britten, N., Barry, C., Bradley, C. and Barber, N. (2002) Perceptions of legitimacy: The influence on medicine taking and prescribing. Health 6, 1: 85-104.
Taylor, D. and Bury, M. (2007) Chronic illness, expert patients and care transition, Sociology of Health and Illness, 29, 1, 27-45.
Tiefer, L. (2006) Female sexual dysfunction: A case study of disease mongering and activist resistance. Public Library of Science – Medicine. 3. 4 (April) e.178.
Turner, B.S. (2004) The New Medical Sociology. Norton.
Zola, I.K. (1972) Medicine as an institution of social control. Sociological Review. 20: 487-503.